Skip to content

Upexi UPXI Reduction Of Acquisition Payable

Reduction Of Acquisition Payable at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.3M+19.7%
Jaguar Uranium
 logo
Jaguar Uranium JAGU
$35.5K
CBIZ logo
CBIZCBZ
$6.3M-78.7%
Payoneer Global Inc. logo
Payoneer Global Inc.PAYO
-$6.52M
Aramark logo
AramarkARMK
-$2.78M-228%
Globus Medical logo
Globus MedicalGMED
$4.32M+11.2%

Other financials

Income statement

See full
Revenue$4.6M+44.2%
Gross profit$4.4M+179%
Operating income-$106.8M-2,877%
Net income-$109.3M-2,754%
EPS (diluted)-$1.67+41.8%

Balance sheet

See full
Cash & equivalents$3.5M+1,412%
Total debt$242.5M+12,119%
Total equity-$51.9M-2,905%
Total assets$200.4M+1,230%

Cash flow

See full
Operating cash flow-$4.8M-513%
CapEx$11.7K-61.7%
Free cash flow-$4.8M-492%

Valuation

See full
Market cap$59.22M-44.5%
Enterprise value$298.19M+121%
P/S2.3×-4.5×

Profitability

See full
Gross margin87%+32.6pp
Operating margin-839.8%-1,002pp
Net margin-874%-1,071pp
FCF margin-83.2%

Returns & leverage

See full
Return on equity-468.5%-935pp
Debt / equity4.4×+3.8×
Current ratio1.7×+1.4×

Where this comes from

Reported directly by Upexi in its filing.

Tagged under the XBRL concept upxi:ReductionOfAcquisitionPayable.

The official record: Upexi’s 10-K, filed September 24, 2025, on SEC EDGAR. View the filing →

Ask your AI about Upexi's reduction of acquisition payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upexi's reduction of acquisition payable?
Upexi (UPXI) reported reduction of acquisition payable of $38.13K in Q2 2025.
What does reduction of acquisition payable mean?
This represents the cash outflow associated with settling liabilities incurred from previous business acquisitions. It provides visibility into the company's ongoing obligations to former owners and the impact of these payments on liquidity.